AI-generated summary
The authors report an observational analysis of 128 women receiving trans-vaginal photobiomodulation for chronic pelvic pain, measuring pain on a 0 to 10 scale over nine treatments. They found that 64.5 percent of women showed improvement in overall pain by the ninth treatment, with reductions meeting the clinically important threshold for several activity-related pains. Because the study is observational and has no control group, the authors describe the improvement only as associated with treatment.
- Participants
- 128
- Who or what was studied
- Women receiving trans-vaginal photobiomodulation therapy for chronic pelvic pain
- Limits stated in the abstract
- The study is observational with no control group, so the reported improvement cannot be attributed to the treatment alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on becarispublishing.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Minimal clinically important difference, Effect size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.